CD44 and melanoma: In contrast, when melanoma cells pretreated with CD44 blocking antibodies were mixed before MEKi treatment with either differentiated TTR or naive macrophages (Figure 7A, bottom panel), CD44 blockade was able to reverse TTR macrophage-mediated protection of MEKi-induced cell death (Figure 7B).